Interventional Radiology Market Size
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 26.96 Billion |
| Market Size (2029) | USD 35.92 Billion |
| CAGR (2024 - 2029) | 5.90 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Interventional Radiology Market Analysis
The Interventional Radiology Market size is estimated at USD 26.96 billion in 2024, and is expected to reach USD 35.92 billion by 2029, growing at a CAGR of 5.90% during the forecast period (2024-2029).
COVID-19 had an impact on the interventional radiology market initially, as hospital and healthcare services were significantly reduced due to social distancing measures taken by governments across the world. For instance, according to an article published by PubMed Central in October 2021, the pandemic dramatically impacted service delivery in many radiology departments across the world. Hence, the pandemic had a significant impact on the market in its initial phase. As the pandemic has subsided and the lockdown restrictions are withdrawn by all countries, the market studied is expected to have stable growth during the forecast period.
The driving factor of the market is the rising trend of minimally-invasive procedures, owing to the cost-effective solutions and lesser hospital stays. With the help of minimally invasive techniques, patients are treated quickly and are usually discharged from the hospital on the same day. Most of these processes require imaging technology.
Innovations in imaging technologies, which provide real-time images to surgeons to show a comprehensive view of internal organs while diagnosing, are driving the interventional radiology market. The major fields of advancement are augmented reality and artificial intelligence. In contrast to virtual reality, where the field of vision for doctors includes no real images, augmented reality offers the ability to move objects (scopes and devices) inside the body and interact with its surroundings. This dynamic development has a variety of applications for image-led interventions. Artificial intelligence uses complex algorithms to detect abnormalities and anomalies in medical images, like CT scans and X-rays. For instance, according to an article published by PubMed Central in February 2022, the implementation of artificial intelligence in diagnostic and interventional radiology may help improve image analysis, aid in diagnosis, and suggest appropriate interventions, clinical predictive modeling, and trainee education, among others.
Chronic diseases persist, often for illnesses or chronic conditions such as heart disease, asthma, cancer, and diabetes. Heart disease is one of the leading causes of death across the world. Until years ago, the treatment for heart disease meant opening a patient's chest to enter directly into the heart with surgery, which was expensive and often exposed the patient to a high risk of infection.
According to the data published by the American Cancer Society in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States in 2022. The high incidence of cancer cases in countries with higher standards of living is primarily due to the availability and access to better diagnostic procedures. Interventional radiology equipment, like CT scanners and MRI systems, are used extensively for these procedures, due to which their demand is expected to increase.
Therefore, owing to the aforementioned factors, the market studied is anticipated to witness growth over the forecast period. However, the risk of high radiation exposure and the high cost of equipment is expected to hinder the growth of the market.
Interventional Radiology Market Trends
This section covers the major market trends shaping the Interventional Radiology Market according to our research experts:
The Cardiology Application is Expected to Witness High Growth Over the Forecast Period
The high incidence of cardiac diseases, increasing utilization of radiology procedures for cardiac disease diagnosis, and the rising geriatric population are some of the factors responsible for the growth of the segment. Cardiac MRI does not use ionizing radiation and is employed for the detection or monitoring of cardiac diseases. It enables the evaluation of the heart's anatomy and functions in patients with heart diseases. According to an article published by PubMed in August 2022, there have been growing uses of intravascular ultrasound (IVUS) during lower extremity arterial and venous revascularization, and observational data suggests that the use of IVUS can improve periprocedural and long-term outcomes in this cardiology procedure. This indicates that the increased utilization of interventional radiology in cardiology may boost the market's growth.
The incidence of cardiovascular disorders in recent years has increased. According to the data updated by CDC in October 2022, heart diseases are the leading cause of death for men, women, and people of most racial and ethnic groups in the United States, and it is estimated that one person dies every 34 seconds in the United States from cardiovascular disease.
As per the study published by the American College of Cardiology in August 2022, cardiac MRI plays a critical and complementary role in the evaluation and surveillance of pericardial diseases, such as pericarditis, pericardial effusion, and pericardial constriction, among others. This is a clear indication that having image-guided devices such as interventional radiology devices in cardiology that help diagnose and treat diseases will ease the process and help physicians maintain accuracy in treating the disease more than any conventional method. This also helps in boosting the market's growth.
In addition, several product launches by companies are also boosting segment growth. For instance, in March 2022, Royal Philips, a global leader in health technology, launched the Ultrasound Workspace at the American College of Cardiology's Annual Scientific Session & Expo. Philips Ultrasound Workspace is a vendor-neutral echocardiography image analysis and reporting solution that can be accessed remotely via a browser.
Thus, in view of the increasing incidences of cardiovascular diseases and new product launches, the market studied is expected to witness growth over the forecast period.
North America to Expected to Dominate the Market Over the Forecast Period
The growing burden of chronic diseases due to changing lifestyles and the increasing need for less expensive interventions are driving the market in the United States. Cardiac catheterization is widely used to diagnose and treat various heart diseases. More than a million cardiac catheterizations and angiographic procedures are performed annually in the United States.
Several radiology interventions can be used to treat cancer patients. For example, transarterial chemoembolization can interrupt blood supply to a tumor, while radiofrequency ablation (RFA) and microwave ablation can damage cancer cells themselves. According to the data from the American Cancer Society in 2022, everyone is at risk of developing cancer. However, the likelihood increases greatly with age. It is estimated that 80% of the people diagnosed with cancer in the United States are 55 years of age or older, and 57% are 65 or older. Also, in the United States, an estimated 40 out of 100 men and 39 out of 100 women are likely to develop cancer during their lifetime. The high prevalence of cases indicates the increased need for radiology interventions for the treatment of patients, which will drive the demand for it in the region.
In addition, new product developments and launches are expected to fuel the growth of the North American market over the forecast period. For instance, in November 2021, Siemens Healthineers launched Naeotom Alpha, one of the world's first photon-counting CT scanners. The system was cleared for clinical use in the United States and Europe.
The rising prevalence of chronic conditions such as cancer and diabetes and the prospects of minimally invasive, targeted treatments using imaging guidance are driving the market in the United States.
Interventional Radiology Industry Overview
The interventional radiology market is highly fragmented and consists of global and local players across the world. Some of the companies that currently dominate the market include GE Healthcare, Fujifilm Holdings Corporation, Koninklijke Philips NV, Siemens AG, and Shimadzu Corporation, among others. However, with technological advancements, it is expected that some small and mid-sized companies will also penetrate the market in the future.
Interventional Radiology Market Leaders
-
Shimadzu Corporation
-
GE Healthcare
-
Koninklijke Philips NV
-
Siemens Healthineers AG
-
Fujifilm Holdings Corporation
*Disclaimer: Major Players sorted in no particular order
Interventional Radiology Market News
- November 2022: Konica Minolta Healthcare Americas launched a new point-of-care ultrasound system called Sonimage MX1 Platinum.
- November 2022: Fujifilm Healthcare Americas Corporation announced the United States launch of the Scenaria View Focus Edition Computed Tomography (CT) system, a premium scanner with an advanced Cardiac Motion Correction feature called Cardio StillShot.
- October 2022: GE Healthcare launched its new all-digital PET/CT platform, Omni Legend, designed to enhance operational efficiency.
Interventional Radiology Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Chronic Diseases
4.2.2 Technological Advancements in Interventional Radiology Devices
4.3 Market Restraints
4.3.1 Risk of High Radiation Exposure
4.3.2 High Cost of Equipment
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product
5.1.1 MRI Systems
5.1.2 Ultrasound Imaging Systems
5.1.3 CT Scanners
5.1.4 Angiography Systems
5.1.5 Fluoroscopy Systems
5.1.6 Biopsy Devices
5.1.7 Other Products
5.2 By Application
5.2.1 Cardiology
5.2.2 Urology and Nephrology
5.2.3 Oncology
5.2.4 Gastroenterology
5.2.5 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Carestream Health
6.1.2 Esaote SPA
6.1.3 GE Healthcare
6.1.4 Fujifilm Holdings Corporation
6.1.5 Hologic Inc.
6.1.6 Koninklijke Philips NV
6.1.7 Shimadzu Corporation
6.1.8 Siemens Healthineers AG
6.1.9 Canon Medical Systems Corporation
6.1.10 Samsung Medison (Samsung Electronics Co. Ltd)
6.1.11 Medtronic PLC
6.1.12 Cook Medical
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Interventional Radiology Industry Segmentation
As per the scope of the report, interventional radiology is the use of radiological image guidance (X-ray fluoroscopy, ultrasound, computed tomography [CT], or magnetic resonance imaging [MRI]) to precisely target the therapy. Most of the treatments that fall under IR are minimally invasive surgeries and the alternatives for open or laparoscopic (keyhole) surgery.
The Interventional Radiology Market is segmented by Product (MRI Systems, Ultrasound Imaging Systems, CT Scanners, Angiography Systems, Fluoroscopy Systems, Biopsy Devices, and Other Products), Application (Cardiology, Urology and Nephrology, Oncology, Gastroenterology, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the world. The report offers the value (in USD million) for all the above segments.
| By Product | |
| MRI Systems | |
| Ultrasound Imaging Systems | |
| CT Scanners | |
| Angiography Systems | |
| Fluoroscopy Systems | |
| Biopsy Devices | |
| Other Products |
| By Application | |
| Cardiology | |
| Urology and Nephrology | |
| Oncology | |
| Gastroenterology | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Interventional Radiology Market Research FAQs
How big is the Interventional Radiology Market?
The Interventional Radiology Market size is expected to reach USD 26.96 billion in 2024 and grow at a CAGR of 5.90% to reach USD 35.92 billion by 2029.
What is the current Interventional Radiology Market size?
In 2024, the Interventional Radiology Market size is expected to reach USD 26.96 billion.
Who are the key players in Interventional Radiology Market?
Shimadzu Corporation, GE Healthcare, Koninklijke Philips NV, Siemens Healthineers AG and Fujifilm Holdings Corporation are the major companies operating in the Interventional Radiology Market.
Which is the fastest growing region in Interventional Radiology Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Interventional Radiology Market?
In 2024, the North America accounts for the largest market share in Interventional Radiology Market.
What years does this Interventional Radiology Market cover, and what was the market size in 2023?
In 2023, the Interventional Radiology Market size was estimated at USD 25.46 billion. The report covers the Interventional Radiology Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Interventional Radiology Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Interventional Radiology Industry Report
The global interventional radiology products market is segmented by product types such as MRI systems, ultrasound imaging systems, CT scanners, angiography systems, fluoroscopy systems, biopsy devices, and other products. This market is further categorized by applications including cardiology, urology and nephrology, oncology, gastroenterology, and other applications. The market is geographically divided into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
The market size and share of interventional radiology products are anticipated to experience significant growth. The market trends indicate a robust expansion driven by advancements in imaging technologies and increasing demand for minimally invasive procedures. The global market analysis highlights the importance of these products in modern medical practices, with a detailed market report providing insights into various segments.
Market research suggests that the industry report offers a comprehensive industry analysis, including a forecast outlook to 2029. The industry overview covers historical data and future predictions, ensuring an in-depth understanding of market dynamics. The market leaders are identified, providing a clear picture of the competitive landscape.
The market forecast and industry information are essential for stakeholders to make informed decisions. The report example and research companies provide valuable data on market segmentation and market value, contributing to the overall market review. The industry trends and market data are crucial for understanding the growth rate and market outlook.
The industry statistics and market predictions emphasize the potential for continued market growth. The industry research and market overview offer insights into the factors driving this growth. The market segmentation and industry size are detailed, ensuring a comprehensive understanding of the market landscape.
The report PDF and industry sales data are available for further analysis. The market growth and industry outlook are positive, with significant opportunities for expansion. The market value and industry reports highlight the importance of interventional radiology products in the healthcare sector. The market review and industry research provide a thorough examination of market dynamics, ensuring a complete understanding of the industry.
